# IN therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/in-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Yongin, South Korea
- Website: www.intherapeutics.com
- Total disclosed funding: $12M
- Latest round: Series A (Feb 26, 2021)
- Investors on record: 8

## About

Founded in 2020 and based in Yongin, South Korea, IN therapeutics is a therapeutics company specializing in new drug development. In February 2022, IN therapeutics raised KRW 26 billion in venture funding from new investors InterVest and STIC Ventures, and returning investors AJU IB Investment, DAYLI Partners, E&Venture Partners, Kiwoom Investment, Shinhan Capital, Time Folio Asset Management, and Yuanta Investment.

The company developed a non-narcotic osteoarthritis analgesic treatment and is completing clinical trials for global pharmaceutical companies.

IN therapeutics plans to accelerate research on pipelines for hearing loss and brain diseases treatment.

## Funding rounds

- Series A, Feb 26, 2021, $12M — AJU IB Investment, Yuanta Investment, Shinhan Capital, Kiwoom Investment, Korea Omega Investment Corp., Time Folio Asset Management, E&Venture Partners, DAYLI Partners

## Investors

- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Series A
- Yuanta Investment (https://capitalatlas.ai/funds/yuanta-investment) — Series A
- Shinhan Capital (https://capitalatlas.ai/funds/shinhan-capital) — Series A
- Kiwoom Investment (https://capitalatlas.ai/funds/kiwoom-investment) — Series A
- Korea Omega Investment Corp. (https://capitalatlas.ai/funds/korea-omega-investment-corp) — Series A
- Time Folio Asset Management — Series A
- E&Venture Partners (https://capitalatlas.ai/funds/e-venture-partners) — Series A
- DAYLI Partners (https://capitalatlas.ai/funds/dayli-partners) — Series A